Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
2(50.0%)
N/A
1(25.0%)
Phase 4
1(25.0%)
4Total
Phase 3(2)
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07321509Phase 4Recruiting

Digoxin After Acute Heart Failure

Role: collaborator

NCT01084070Phase 3Completed

Early Oral Feeding Versus Traditional Postoperative Care in Emergency Abdominal Surgery

Role: lead

NCT00536003Phase 3Terminated

Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor

Role: collaborator

NCT01432548Not ApplicableUnknown

Ischemic Preconditioning. Prospective Comparison

Role: lead

All 4 trials loaded